Selinexor-Based Triplet Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies.
Gary J. Schiller,Brea C. Lipe,Nizar J. Bahlis,Sascha A. Tuchman,William I. Bensinger,Heather J. Sutherland,Suzanne Lentzsch,Muhamed Baljevic,Darrell White,Rami Kotb,Christine I. Chen,Adriana Rossi,Noa Biran,Richard Leblanc,Sebastian Grosicki,Maurizio Martelli,Eberhard Gunsilius,Ivan Spicka,Don Ambrose Stevens,Thierry Facon,Mercedes Gironella Mesa,Chris Zhang,Dane R. Van Domelen,Ohad S. Bentur,Cristina Gasparetto Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2023）
关键词
Oral selective inhibitor of nuclear export,High-risk,Triplet,Relapsed/refractory,Heavily pre-treated disease
AI 理解论文
溯源树
样例
